U.S. Markets closed

Should Pfizer Investors Worry About Tomorrow's FDA Meeting?

·4 min read
Should Pfizer Investors Worry About Tomorrow's FDA Meeting?
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Tomorrow is a big day for Pfizer (NYSE: PFE). A U.S. Food and Drug Administration advisory committee will review its latest request. The coronavirus vaccine leader is asking for the authorization of its booster shot.